Antibody responses to human rotavirus (HRV) in gnotobiotic pigs following a new prime/boost vaccine strategy using oral attenuated HRV priming and intranasal VP2/6 rotavirus-like particle (VLP) boosting with ISCOM.
about
Innate immune responses induced by the saponin adjuvant Matrix-M in specific pathogen free pigs.An oral versus intranasal prime/boost regimen using attenuated human rotavirus or VP2 and VP6 virus-like particles with immunostimulating complexes influences protection and antibody-secreting cell responses to rotavirus in a neonatal gnotobiotic piA human norovirus-like particle vaccine adjuvanted with ISCOM or mLT induces cytokine and antibody responses and protection to the homologous GII.4 human norovirus in a gnotobiotic pig disease model.Rectal immunization with rotavirus virus-like particles induces systemic and mucosal humoral immune responses and protects mice against rotavirus infection.Prime immunization with rotavirus VLP 2/6 followed by boosting with an adenovirus expressing VP6 induces protective immunization against rotavirus in miceHigh titers of circulating maternal antibodies suppress effector and memory B-cell responses induced by an attenuated rotavirus priming and rotavirus-like particle-immunostimulating complex boosting vaccine regimenISCOM-based vaccines: the second decade.PBMC transcriptomic responses to primary and secondary vaccination differ due to divergent lean growth and antibody titers in a pig modelHigh protective efficacy of rice bran against human rotavirus diarrhea via enhancing probiotic growth, gut barrier function, and innate immunityAdvances in swine biomedical model genomicsVirus-specific intestinal IFN-gamma producing T cell responses induced by human rotavirus infection and vaccines are correlated with protection against rotavirus diarrhea in gnotobiotic pigs.Development of a human rotavirus induced diarrhea model in Chinese mini-pigs.Properties and applications of nanoparticle/microparticle conveyors with adjuvant characteristics suitable for oral vaccination.
P2860
Q33717300-A655CF30-4AED-417C-AF85-C1E49C0B6043Q33725133-1ED905D1-87DB-42DE-8D49-7339CF4C22FFQ33889379-5D322EE4-EDDC-4092-BE67-406730DC18E1Q34353344-00EB7450-021E-46B3-8F23-F6A6E527BE9FQ34510430-ECB8BA30-9832-4A68-9BE9-42636BAADD47Q34601460-3CD6463D-D105-4DC8-95FA-3C0E35EF35CDQ36062124-49AADA51-1532-4F10-92B4-4F4BDE85C7FEQ36122828-B390E536-6393-44F9-A435-FFC2AF672D9FQ36149919-B7D1AF10-3AED-4D00-A211-E0900C3E005AQ36769902-14B8AC8A-1689-4E18-9383-A175E9A61310Q36953220-30A479ED-D6EA-4314-BBCB-D7A878F0BC72Q39175760-46150F68-2C08-40E9-BFBA-ACF929706B55Q55326313-F695120B-6C13-4691-AAD4-AD8AA4BBDA28
P2860
Antibody responses to human rotavirus (HRV) in gnotobiotic pigs following a new prime/boost vaccine strategy using oral attenuated HRV priming and intranasal VP2/6 rotavirus-like particle (VLP) boosting with ISCOM.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Antibody responses to human ro ...... cle (VLP) boosting with ISCOM.
@en
Antibody responses to human rotavirus
@nl
type
label
Antibody responses to human ro ...... cle (VLP) boosting with ISCOM.
@en
Antibody responses to human rotavirus
@nl
prefLabel
Antibody responses to human ro ...... cle (VLP) boosting with ISCOM.
@en
Antibody responses to human rotavirus
@nl
P2093
P2860
P1476
Antibody responses to human ro ...... cle (VLP) boosting with ISCOM.
@en
P2093
A M González
K Lovgren-Bengtsson
M S P Azevedo
T V Nguyen
P2860
P304
P356
10.1111/J.1365-2249.2004.02395.X
P577
2004-03-01T00:00:00Z